DNA ploidy, bromodeoxyuridine labelling index, S - phase fraction and AgNOR counts in brain tumours

Reports of Practical Oncology and Radiotherapy

Volumn 5, Issue 3, 2000, Pages 75-81

  Anna, Gasińska ^a   Joanna, Niemiec ^a   Agnieszka, Adamczyk ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Brain tumours; Bromodeoxyuridine labelling index; DNA ploidy; Nucleolar organizer regions (agnor); Proliferation rate; Spf

Indexed keywords

EID: 84862983517     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(00)70364-6     Document Type: Article

References (24)

1. Steel GG. Growth kinetics of tumours. Oxford: Clarendon Press 1977.
2. Riccardi A, Danova M, Wilson G, et al. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res 1988; 48: 6238 - 45.
3. Danova M, Gaetani P, Lombardi D. et al. Prognostic value of DNA ploidy and proliferative activity in human malignant gliomas. Med Sci Res 1991; 19: 613-5.
4. Steel GG, Bensted JPM. In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical consideration. Eur J Cancer 1965; 1: 276 - 9.
5. Nishizaki T. Orita T, Furutani V, et al. Flowcytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 1989; 70: 379 384.
6. Torp SH. Helseth E. Dalen A, Unsgaard G. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir 1992; 117: 182 - 6.
7. Revesz T, Alsanjari N, Darling JL, et al. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas. Neuropathol. Appl Neurobiol1993; 19: 152 - 8.
8. Shibuya M. Ito S, Miwa T, et al. Proliferative potential of brain tumors. Cancer 1993; 71: 199 206.
9. Engel U, Plate K, Jänisch W, Mennel HD. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. Zentralbl Pathol 1994; 140: 73 - 81.
10. Gilbert N, Lucas L, Klein C, et al. Three dimensional co - location of RNA polymerase I and DNA during interphase and mitosis by confocal microscopy. J Cell Sci 1995; 108: 115 - 25.
11. Kernohan JW, Sayre GP. Tumors of the central nervous system. American Registry of Pathology, AFIP, Washington 1952.
12. Gasir'lska A, Zabagło L, Cichocka A. et al. Argyrophilic nucleolar organizer regions and bromodeoxyuridine labelling index in squamous cell carcinoma of the cervix. Folia Histochem Cytobiol 1996; 34: 95 ·101.
13. Hoshino T. Ahn D, Prados MD, et al. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. lnt J Cancer 1993; 53: 550-5.
14. Gasir'lska A. Krzyszkowski T, Skofyszewski J, et al. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours. Folia Histochem Cytobiol 1998; 36: 127 - 32.
15. Fujimaki T, Matsutani M, Nakamura O, et al. Correlation between bromodeoxyuridine labeling indices and patient prognosis in cerebral astrocytic tumors of adults. Cancer 1991; 67: 1629 - 34.
16. Barker FG, Prados MD, Chang SM, et al. Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival. Int I Radiat Oncol Bioi Phys 1996; 34: 803-8.
17. Struikmans H, Rutgers DH, Jansen GH, et al. Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas. Acta Neurochir (Wien) 1998; 140: 140-7.
18. Hoshino T. Prados M, Wilson C.B. et al. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. J Neurosurg 1989; 71: 335 - 41.
19. Krzyszkowski T, Gasińska A, Danilewicz B, Skotyszewski J. Czy parametry kinetyki komórkoweji ploidalnosci DNA maja znaczenie prognostyczne u chorych na nowotwory mózgu? Biuletyn Wojskowego Szpitala Klinicznego 1997; 2: 48 - 52.
20. Coons SW, Johnson P C, Pearl OK, et al. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 1994; 34: 680 - 7.
21. Ferreres JC, Figols J, Val-Bernal JF, et al. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value. Histol istopathol 1996; 11: 35 - 9.
22. Haberland C, Martin H, Guski H, et al. AgNOR analysis of astrocytoma in childchood. Zentralbl Neurochir 1996; 57: 5 - 11.
23. Trere 0, Farabegoli F, Cancellieri A, et al. AgNOR area in interphase nuclei of human tumours correlates with the proliferativeactivity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol1991 165: 53 - 9.
24. Onda K, Davis RL, Wilson Ch S, Hoshino T. Regional differences in bromodeoxyuridine uptake, expression of Ki - 67 protein, and nucleolar organizer region counts in glioblastoma multiforme. Acta Neuropathol (Berl) 1994; 87: 586 - 93.